Ontario Minister of Health to film AstraZeneca to fight vaccine hesitancy

0
11
Ontario Minister of Health to film AstraZeneca to fight vaccine hesitancy


TORONTO – Ontario’s health minister says she will film AstraZeneca to fight vaccine reluctance and prove to residents that the vaccine is safe.
“It’s unfortunate that there is still a lot of vaccine hesitation around AstraZeneca,” Elliott said Monday. “Sure, it works, it prevents hospitalizations and it saves people’s lives.”

The shooting has been the subject of concern in recent weeks following reports of blood clots in a handful of people who received it in Europe.

More than 15 European countries stopped using AstraZeneca injections last week pending an investigation by the European Medicines Agency (EMA). The EMA will later state in a review of the AstraZeneca vaccine that it has found no evidence that the injection increases the overall risk of blood clots.

Health Canada doubled down on that finding on Thursday by saying that the benefits of the shot far outweighed the risks associated with catching COVID-19.

There has been only one report of stroke in a person following vaccination with the AstraZeneca vaccine version in Canada, which health officials have determined to be unrelated to the vaccine.

Elliott’s announcement comes days after his Quebec counterpart, the Minister of Health, Christian Dubé, received his vaccine in front of the camera. Dubé said at the time that he wanted to document his inoculation to set a good example for others while allaying fears about AstraZeneca’s safety, a sentiment Elliott echoed on Monday.

“If I could convince another person to get the AstraZeneca vaccine, and it helps protect them, their health and safety and that of their families, I am more than happy to do so,” he said. she declared.

Ontario began rolling out the AstraZeneca vaccine in select pharmacies and doctor’s offices across the province to people aged 60 to 64 two weeks ago.

Since then, Canada’s National Advisory Committee on Immunization (NACI) has revised its recommendations for the vaccine, authorizing its use for people 65 years of age and older.

LEAVE A REPLY

Please enter your comment!
Please enter your name here